Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Coxsackievirus A10/CA10 VP1/Capsid protein VP1 Protein, N-His

Catalog #:   YVV20701 Specific References (28) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: G8YY52
Protein length: Gly85-Met382
Overview

Catalog No.

YVV20701

Expression system

E. coli

Species

Coxsackievirus A10

Protein length

Gly85-Met382

Predicted molecular weight

35.49 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

G8YY52

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Genome polyprotein, VP1, Capsid protein VP1

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Coxsackievirus/CV VP1/Capsid protein VP1
References

Discovery of a broad-spectrum monoclonal antibody recognizing a conserved, linear epitope WFYDGYPT on VP1 protein of Enterovirus A species., PMID:39736634

Antiviral activity of povidone-iodine gargle and mouthwash solution against Enterovirus A71, Coxsackieviruses A16, A10 and A6., PMID:39548776

Molecular characteristics of the structure protein VP1 in Coxsackievirus A10 Isolates from China., PMID:39078798

Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease., PMID:38705805

Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening., PMID:38452856

Identification of Critical Amino Acids of Coxsackievirus A10 Associated with Cell Tropism and Viral RNA Release during Uncoating., PMID:37896891

An enterovirus A71 virus-like particle with replaced loops confers partial cross-protection in mice., PMID:37788720

Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection., PMID:37112912

Epidemiology of Hand, Foot, and Mouth Disease and Genetic Evolutionary Characteristics of Coxsackievirus A10 in Taiyuan City, Shanxi Province from 2016 to 2020., PMID:36992403

Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10., PMID:36457099

Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice., PMID:36373411

First evidence of enterovirus A71 and echovirus 30 in Uruguay and genetic relationship with strains circulating in the South American region., PMID:34383835

Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1., PMID:32690697

Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China., PMID:32264839

Genetic characterization of VP1 of coxsackieviruses A2, A4, and A10 associated with hand, foot, and mouth disease in Vietnam in 2012-2017: endemic circulation and emergence of new HFMD-causing lineages., PMID:32008121

The surveillance of the epidemiological and serotype characteristics of hand, foot, mouth disease in Neijiang city, China, 2010-2017: A retrospective study., PMID:31170178

Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden., PMID:30669973

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10., PMID:30255146

Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet Nam 1997-2010., PMID:29650033

A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection., PMID:29470994

Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015., PMID:28577423

Epidemiological and genetic analysis concerning the non-enterovirus 71 and non-coxsackievirus A16 causative agents related to hand, foot and mouth disease in Anyang city, Henan Province, China, from 2011 to 2015., PMID:28480969

A real-time RT-PCR assay for rapid detection of coxsackievirus A10., PMID:26782393

Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3., PMID:24392117

Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011., PMID:23272213

Molecular identification of enteroviruses associated with aseptic meningitis in children from India., PMID:22975986

Molecular typing and epidemiology of enteroviruses in Cyprus, 2003-2007., PMID:21596905

The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains., PMID:20952237

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Coxsackievirus A10/CA10 VP1/Capsid protein VP1 Protein, N-His [YVV20701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only